<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004967"><a href="http://purl.obolibrary.org/obo/MONDO_0004967">MONDO:0004967</a></h3>
<p><strong>Label:</strong> acute lymphoblastic leukemia (disease)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0004963">MONDO:0004963</a> (T-cell acute lymphoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0020511">MONDO:0020511</a> (precursor b-cell acute lymphoblastic leukemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_99860">Orphanet:99860</a>, <a href="http://purl.obolibrary.org/obo/OMIM_186770">OMIM:186770</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615545">OMIM:615545</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 34.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 34.12%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 33.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 31.43%</li>
<li>Thing 31.42%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 31.42%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 28.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) and <a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 28.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) and <a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 27.96%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) and <a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 25.54%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 24.75%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 24.75%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0010987">HP:0010987</a> (Abnormality of cellular immune system) 24.75%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 22.59%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 22.11%</li>
</ul>
</body>
</html>
